Diaphragmatic hernia medical therapy

Jump to navigation Jump to search


Diaphragmatic hernia Main page

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Differentiating Diaphragmatic hernia from other Diseases

Epidemiology

Risk factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Radiological tests

Treatment

Medical treatment

Surgical treatment

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Ahmed Younes M.B.B.CH [2]

Overview

Antenatal glucocorticoids improve the survival by increasing surfactant secretion. Postnatal medical management is focused on stabilizing the infant before surgical intervention.

Medical treatment

Antenatal glucocorticoids

Antenatal glucocorticoids improve the survival by increasing the secretion of surfactant and thus stimulating lung maturation and preventing severe pulmonary hypoplasia.[1]

Preoperative stabilization

  • Preoperative stabilization of the patient is important as performing the operation in an unstable infant is associated with higher morbidity and mortality rates.
  • Preoperative stabilization measures include:[2]

References

  1. Badillo A, Gingalewski C (2014). "Congenital diaphragmatic hernia: treatment and outcomes". Semin. Perinatol. 38 (2): 92–6. doi:10.1053/j.semperi.2013.11.005. PMID 24580764.
  2. 2.0 2.1 Kesieme EB, Kesieme CN (2011). "Congenital diaphragmatic hernia: review of current concept in surgical management". ISRN Surg. 2011: 974041. doi:10.5402/2011/974041. PMC 3251163. PMID 22229104.